INSTITUT CLAUDIUS REGAUD
🇫🇷France
Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy
Phase 2
Recruiting
- Conditions
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 45
- Registration Number
- NCT04513444
- Locations
- 🇫🇷
Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma?
Not Applicable
Completed
- Conditions
- First Posted Date
- 2020-08-13
- Last Posted Date
- 2021-12-10
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 60
- Registration Number
- NCT04512495
- Locations
- 🇫🇷
Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 130
- Registration Number
- NCT04428554
- Locations
- 🇫🇷
Institut Andrée Dutreix, Dunkerque, France
🇫🇷Clinique Claude Bernard, Albi, France
🇫🇷CHU Besançon, Besançon, France
Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC
Completed
- Conditions
- First Posted Date
- 2020-04-29
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 100
- Registration Number
- NCT04368468
- Locations
- 🇫🇷
Institut claudius regaud, Toulouse, France
Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-03-13
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 600
- Registration Number
- NCT04307277
- Locations
- 🇫🇷
CHRU Besançon, Besançon, France
🇫🇷Centre Georges-François Leclerc, Dijon, France
🇫🇷Institut Paoli-Calmettes, Marseille, France
CINSARC Genomic Signature as Predictor of Resectability of Ovarian Adenocarcinoma
Completed
- Conditions
- First Posted Date
- 2020-01-30
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 150
- Registration Number
- NCT04248231
- Locations
- 🇫🇷
Institut Claudius Regaud Institut Universitaire du cancer Toulouse Oncopole, Toulouse, France
E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer.
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-01-14
- Last Posted Date
- 2021-07-27
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 45
- Registration Number
- NCT04228432
- Locations
- 🇫🇷
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection.
Completed
- Conditions
- First Posted Date
- 2019-06-14
- Last Posted Date
- 2021-05-27
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 29
- Registration Number
- NCT03986437
- Locations
- 🇫🇷
IUCT-O, Toulouse, France
Role of Surgery in Advanced Ovarian Cancer
Completed
- Conditions
- First Posted Date
- 2019-06-10
- Last Posted Date
- 2019-06-10
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 550
- Registration Number
- NCT03980028
- Locations
- 🇫🇷
Institut Claudius Regaud - IUCT-Oncopole, Toulouse, Occitanie, France
Evaluation of the Adhesion to the GENEPY Network
- First Posted Date
- 2019-06-07
- Last Posted Date
- 2019-06-07
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 450
- Registration Number
- NCT03979612
- Locations
- 🇫🇷
Institut Claudius Regaud - IUCT-Oncopole, Toulouse, Occitanie, France
© Copyright 2024. All Rights Reserved by MedPath